Singular Genomics Systems, Inc. 8-K Report: Key Updates from February 13, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

Entity Information:

Name: Singular Genomics Systems, Inc.
CIK: 0001850906
State of Incorporation: Delaware (DE)
IRS Employer Identification Number: 81-2948451
Address: 3010 Science Park Road, San Diego, CA 92121
Phone Number: 858-333-7830

Filing Details:

Filing Type: 8-K (Current Report)
Filing Date: February 13, 2025
Period Covered: The report covers a single date, February 13, 2025.

Stock Information:

Common Stock Par Value: $0.0001 per share
Trading Symbol: OMIC
Exchange: NASDAQ

Reporting Context:

The report is structured in XBRL (eXtensible Business Reporting Language), which is a format used for financial reporting.

Document Reference:

The schema reference for the document is "omic-20250213.xsd".

Insights:

The 8-K filing is typically used to report significant events that shareholders should know about, indicating that something notable occurred on or around February 13, 2025.
The choice of filing an 8-K suggests that Singular Genomics Systems, Inc. might have experienced an event such as a merger, acquisition, change in executive leadership, or a major financial event.
Singular Genomics is listed on NASDAQ under the symbol OMIC, indicating it is a publicly traded company, which provides context for the importance of timely and accurate disclosures to investors.

This information provides a snapshot of the company and its activities as of the specified date, which can be critical for analyzing the company's performance and future potential. Further details would likely be found in the body of the 8-K filing itself.